Email bulletins

To sign up for our monthly hepatitis news bulletins, please enter your details below.

Email

Repeat email

Country

Primary interest

Preferred language

Please note, this bulletin is in English.
When we report from The International Liver Congress (April) and The Liver Meeting (November), the bulletin is also available in French, Spanish, Portuguese and
Russian. If you would like to sign up to one of these translated bulletins, please choose your language from the list below.

To unsubscribe, please click here.

Archive

May 2019

World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans
Bulevirtide is a potential cure for hepatitis B and D
Is opt-out testing for HCV improving testing rates in UK prisons?
First paediatric pangenotypic treatment
NHS England strikes world leading deal to help eliminate hepatitis C
NHS England instructs GPs to do more hepatitis C testing after blood scandal
Is this your copy of the infohep news bulletin?

April 2019

News from The International Liver Congress, Vienna
Hepatitis C elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment
30 million screened for hepatitis C in four months in Egypt
Same-day diagnosis and treatment initiation for viral hepatitis
Hepatitis B cure strategy launched
Experimental hepatitis B drug produces deep and rapid decline in HBV DNA
Non-alcoholic fatty liver disease and NASH
NAFLD in people living with HIV
Simplified monitoring and highly effective treatment for hepatitis C
Tenofovir and liver cancer in HBV
Is this your copy of the infohep news bulletin?

March 2019

Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up
HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers
US Department of Veterans Affairs on track to cure 100,000 of hepatitis C
Hepatitis C treatment reduces risk of diabetes
Hepatitis C treatment safe and effective in pregnant women, pilot study shows
Hepatitis B virus raises the risk of age-related macular degeneration
EndHep2030 call for proposals
World Hepatitis Alliance appoints new CEO and President
Next month: News from The International Liver Congress
Is this your copy of the infohep news bulletin?

February 2019

DAA treatment reduces the risk of death and liver cancer in France
Experimental therapy improves liver health in people with fatty liver disease
Immunotherapy combinations show promise for liver cancer
Generic treatment and hepatitis C elimination in Egypt
Hepatitis C cure does not improve long-term glucose control
Tackling HIV and hepatitis C in Europe: towards minimum standards
Improving the uptake of hepatitis C care in people who inject drugs
Is this your copy of the infohep news bulletin?

January 2019

Lancet Commission recommends actions to support elimination of hepatitis C
HCV modelling study
HIV/HCV co-infection and end-stage liver disease
Survival after liver cancer diagnosis is shorter in people living with HIV
Conditional cash transfers to encourage hepatitis C diagnosis and treatment in people who inject drugs
Barriers to HCV treatment in people who inject drugs
TAF for hepatitis B
AbbVie legal challenge in UK tender exercise dismissed
Is this your copy of the infohep news bulletin?